Literature DB >> 7077805

Adverse effect of hydralazine in patients with primary pulmonary hypertension.

I Kronzon, M Cohen, H E Winer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7077805

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series).

Authors:  Jessica H Huston; John J Ryan
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 2.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

3.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

Review 4.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

5.  Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.

Authors:  David Langleben; Stylianos Orfanos
Journal:  Pulm Circ       Date:  2017-06-20       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.